Mabspace Biosciences

Platform for antibody discovery and development

placeHong Kong, Hong Kong, China calendar_todayFounded 2013 groups60 employees language mabspacebio.com

Innovation

3 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 126 times.

YearFilings
20171
20181
20191
20201
20213

Investor mix

3 investors on record; lead investors include Lilly Asia Ventures, Sequoia Capital.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon